254. ポルフィリン症 Porphyria Clinical trials / Disease details

臨床試験数 : 72 / 薬物数 : 53 - (DrugBank : 16) / 標的遺伝子数 : 19 - 標的パスウェイ数 : 35

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02979249 (ClinicalTrials.gov)	December 2016	29/11/2016	Oral Iron for Erythropoietic Protoporphyrias	Effect of Oral Iron Therapy on Erythrocyte Protoporphyrin Levels in the Erythropoietic Protoporphyrias	Erythropoietic Protoporphyria;EPP;X-linked Protoporphyria;XLP	Drug: Oral Iron	Icahn School of Medicine at Mount Sinai	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	Completed	18 Years	N/A	All	16	N/A	United States
2	NCT01284946 (ClinicalTrials.gov)	January 2011	26/1/2011	Safety and Efficacy of Oral Deferasirox in Patients With Porphyria Cutanea Tarda	A Phase II, Open Label Clinical Trial Exploring the Safety and the Efficacy of Oral Deferasirox in Patients Newly Diagnosed With Porphyria Cutanea Tarda (PCT) and Non-transfusion Iron Overload	Porphyria Cutanea Tarda	Drug: Exjade	Assistance Publique - Hôpitaux de Paris	Association pour l'Etude des Fonctions Digestives (AEFD)	Recruiting	18 Years	N/A	Both	45	Phase 2	France